Clinical Trial Update: IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study [Phase 2]

View source ↗

Summary

IMD-1041 is being evaluated in a Phase 2 proof-of-concept trial for Chronic Obstructive Pulmonary Disease, with the current trial status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• IMD-1041

Snippet

Sponsor: Institute of Medicinal Molecular Design, Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: UNKNOWN